Complete your CME and MOC Requirements Online with BoardVitals Online CME + MOC Self-Assessment Activity with FREE $1,000 AMAZON or APPLE GIFT CARD. Answer board-style questions and cases related to your specialty and earn credits fast!

Key features of BoardVitals Online CME + MOC Self-Assessment Activity include:
Thousands of board-style questions and cases with evidence-based explanations for review
Aligned with the MOC / Recertification exam content for each specialty board
Answer questions to earn credits and correct wrong answers as you go
Earn up to 100 AMA PRA Category 1 Credits and MOC credits (varies by specialty)
12-month access + $1,000 Amazon or Apple Gift Card (your choice!)

ScientiaCME Pain Management has three lectures:

Pain – Neuropathic
• Multiple Sclerosis (MS) in a Primary Care Setting: Employing Strategies for Appropriate Diagnosis and Improved Patient Outcomes (1 hr CME)
• Therapeutic Updates, Best Practices and Barriers to Care in the Prevention and Treatment of Multiple Sclerosis (1 hr CME)

Pain – Somatic
• Therapeutic Updates, Best Practices, and Barriers to Care in the Treatment of Chronic Pain (1 hr CME)

In order to get credit from ScientiaCME, you must first establish a username and password.

Target Audience: Physicians focusing on Pain Management

Topics covered by Intensive Update in Pain Management include: Spinal Cord Stimulation, Anatomic Imaging for Pain Evaluation, Cannabinoids for Chronic Pain, Fibromyalgia, Peripheral Nerve Stimulation, Opioid Epidemic, Lumbar Spinal Fusion, Exercise, Sodium Nitrite for Peripheral Neuropathy, 5HT Agonist for Neuropathic Pain and many more.
Upon completion of Intensive Update in Pain Management, you will be able to:
Define the role of DRG stimulation within the spectrum of neuromodulation therapies
Identify patient selection criteria for neuromodulation therapies
Develop strategies to provide affordable pain care that addresses the economic impact of health care reform
Recognize pain conditions and symptoms that would trigger patient referral for surgical treatment
Summarize the role of rheumatologic conditions in chronic pain development and treatment
List the technical skills needed to perform interventional pain procedures
Use multidisciplinary and multimodal pain treatments to treat chronic pain conditions
Apply CDC guidelines to chronic opioid treatment to improve safety and reduce adverse effects associated with their use.

Target Audience: Practitioners and healthcare professionals who seek to learn the latest developments in pain medicine, including anesthesia providers, interventional pain specialists, physical medicine and rehabilitation specialists, orthopaedic and spine surgeons, neurologists, neurosurgeons, headache specialists, palliative care specialists, primary care physicians, physical therapists, physician assistants, nurse practitioners and residents and fellows in training.

Learn about the treatment of chronic pain and substance abuse with the BoardVitals Chronic Pain Management & Substance Abuse CME Activity.

Features include:
• 100 Chronic Pain Management & Substance Abuse questions
• Detailed rationales and explanations for each answer
• Up to 7 AMA PRA Category 1 Credits
• 12 months access

After completing the BoardVitals Chronic Pain Management & Substance Abuse CME Activity, you should be able to:
• Identify the most commonly abused substances
• Recognize the most common indicators and symptoms of substance abuse and pain medicine dependency
• Describe the underlying pathophysiology of disease and basic science knowledge
• Formulate treatment for chronic pain management and substance abuse

Target Audience:
Care providers concerned about issues of chronic pain and substance abuse.

Improving Outcomes in Chronic Pain will help you to:
Assess and measure pain and its effects on your patients;
Choose appropriate therapies for chronic pain;
Better manage common pain syndromes; and
Safeguard your practice from drug abuse and diversion.

After viewing Updates in Migraine Headaches, you will be able to:
• Describe the prevalence of migraine symptoms and the impact that these symptoms have on efficacy of anti-migraine therapy and functional status
• Describe the sometimes variable manifestations (e.g., incidence and clinical presentation) of migraine headaches, depending on age and sex
• Recall emerging therapies for the treatment and prevention of chronic migraine headache and anticipate their place in therapy
• Support team-based learning and communication between all clinicians involved with the care of patients suffering with migraines
• Given a series of patient cases, diagnosis and treat migraine headaches by employing current treatment guidelines, using evidence-based therapy algorithms, and providing individualized approaches to care

Target Audiences:
Healthcare professionals who are: primary care physicians, neurologists, headache specialists, nurse practitioners, physician assistants, nurses, OB-GYN specialists, pharmacists, and those who otherwise commonly care for or clinically encounter patients who may experience migraine headache.

This comprehensive Addiction Medicine CME bundle offers physicians up to 40 AMA PRA Category 1 Credits^TM and comes with a free $1,000 Amazon or Apple gift card.

This Addiction Medicine CME bundle is constantly updated and covers the most relevant and up to date topics in Addiction Medicine including:

• Neurobiology of Addiction
• Pain and Addiction
• Genetics, Dysmorphology, and Metabolic Disorders
• Behavioral Interventions
• Co-Occurring Disorders
• Behavioral Interventions

In addition to earning CME credits, this Addiction Medicine CME activity is a great option to help physicians prepare for their American Board of Addiction Medicine board certification or recertification exams.

Here is a complete list of features in the BoardVitals Addiction Medicine CME Bundle:

• Free $1,000 Amazon or Apple Gift Card
• 40 AMA PRA Category 1 Credits^TM
• Addiction Medicine Board Style Questions and cases with detailed explanations
• 12-month access
• Computer, Mobile, and Tablet access – Learn anytime, anywhere

Opioid Prescribing Practices is a two-part audio series examining the clinician’s role in combating an opioid epidemic that grips our country.
PART 1 is Managing Opioid Therapy in High-Risk Patients
PART 2 is The Opioid Epidemic
Upon completion of Opioid Prescribing Practices, you will be able to:
• Define the terms ‘pain’ and “chronic pain.”
• Provide examples of potential high-risk patients for opioid misuse.
• Describe how a health care provider might assess a patient’s chronic pain and measure the outcomes after initiating treatment.
• List at least five non-opioid drugs that may offer first-line therapy for non-cancer-related pain management.
• Summarize the Centers for Disease Control’s (CDC) guidelines that pertain to proper prescribing practice for pain medications.
• State whether the incidence of providers actually losing their license or having any legal action taken against them regarding opioid prescribing practices is large or small.
• Describe Prescription Drug Monitoring Programs and discuss their use in the prescribing of opioid medications.
• And much more.

Target Audience: Physicians, Nurse Practitioners, Physician Assistants, Dentists, and Oral and Maxillofacial Surgeons.

Alcohol Use Disorder (AUD): Therapeutic Updates and Best Practices covers the epidemiology, diagnosis and treatment of Alcohol Use Disorder and consists of a single lecture by Timothy Fong MD.

After participating in Alcohol Use Disorder (AUD): Therapeutic Updates and Best Practices , you will be able to:
• Describe the epidemiology of AUD and outline current and evolving diagnostic criteria
• Describe challenges to the successful identification of patients with AUD
• Identify the treatment modalities currently available for management of AUD and apply them to patient cases using evidence-based medicine
• Develop strategies for recognizing and improving therapeutic adherence in patients treated for AUD

Target Audience:
Psychiatrists, primary care physicians, emergency medicine physicians, physician assistants, nurse practitioners, pharmacists, and those healthcare professionals who commonly treat patients suffering from or have a clinical interest in AUD.